Changes in Capillary Carbon Dioxide Partial Pressure (pCO2) While Wearing FFP2 / FFP3 Masks

Sponsor
Medical University of Vienna (Other)
Overall Status
Recruiting
CT.gov ID
NCT04980820
Collaborator
(none)
200
1
2
16.4
12.2

Study Details

Study Description

Brief Summary

The aim of this study is to determine whether there are any changes in the carbon dioxide partial pressure in medical staff while wearing a filtering face piece (FFP) 2 or FFP3 mask.

Furthermore, changes in the capillary oxygen partial pressure, the subjective respiratory effort and the breathing rate are measured.

Condition or Disease Intervention/Treatment Phase
  • Other: No mask
  • Device: Filtering face mask 2 (FFP2)
  • Device: Filtering face mask 3 (FFP3)
N/A

Detailed Description

In the fight against the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the personal protective equipment (PPE) of medical staff plays a special role. Since the pathogen can be transmitted via droplets, particle-filtering half masks (filtering face piece

  • FFP) are a substantial part of the PPE. The current data indicate that there may be an increase in the carbon dioxide partial pressure (PcCO2) in the blood when wearing an FFP2 / 3 mask during routine medical activity.

The aim of this prospective cross-over study is to compare the PcCO2 measured by capillary blood sampling from medical staff while wearing an FFP2 or FFP3 mask. The PcCO2 determined without a mask serves as a reference value. While no mask is worn, the PcCO2, the subjective respiratory effort, the breathing rate and the capillary oxygen partial pressure (PcO2) is measured. The study participants then wear an FFP2 or FFP3 mask for one hour, and the same parameters are collected. Subsequently, the participant switches to an FFP3 or FFP2 mask, and the last measurement is conducted after one hour.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
arm: starts with no mask - FFP2 mask - FFP3 mask arm: starts with no mask - FFP3 mask - FFP2 maskarm: starts with no mask - FFP2 mask - FFP3 mask arm: starts with no mask - FFP3 mask - FFP2 mask
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Changes in Capillary pCO2 While Wearing FFP2 and FFP3 Masks Masks by Medical Staff - a Prospective Cross-over Study
Actual Study Start Date :
Jul 19, 2021
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: FFP2

This arm starts with a FFP2 mask and switches to a FFP3 mask.

Other: No mask
The participant is asked to wear no mask for 10 minutes.

Device: Filtering face mask 2 (FFP2)
The participant is asked to wear a FFP2 mask for 1 hour during work.

Device: Filtering face mask 3 (FFP3)
The participant is asked to wear a FFP3 mask for 1 hour during work.

Experimental: FFP3

This arm starts with a FFP3 mask and switches to a FFP2 mask.

Other: No mask
The participant is asked to wear no mask for 10 minutes.

Device: Filtering face mask 2 (FFP2)
The participant is asked to wear a FFP2 mask for 1 hour during work.

Device: Filtering face mask 3 (FFP3)
The participant is asked to wear a FFP3 mask for 1 hour during work.

Outcome Measures

Primary Outcome Measures

  1. Change of PcCO2 [1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)]

    Change of capillary carbon dioxide partial pressure (PcCO2)

Secondary Outcome Measures

  1. Change of PcO2 [1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)]

    Change of capillary oxygen partial pressure (PcO2)

  2. Respiratory rate [1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)]

    Number of breaths per minute

  3. Exertion score [1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)]

    Participant subjective score: "How difficult is it for you to breathe at the moment?"; scale from 1-5, 1= easy, 2= rather easy, 3= moderate, 4= rather hard, 5= hard

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • medical staff working at the Vienna General Hospital

  • oral and written consent to take part voluntarily in this trial

Exclusion Criteria:
  • hypersensitivity / allergy against Nonylvanillamid, Nikotinsäure-beta-butoxyethylester or other component of "Finalgon Salbe"

  • not Coronavirus disease-19 vaccinated

  • pregnancy

  • breastfeeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Vienna Vienna Austria

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

  • Principal Investigator: Georg Röder, M.D., Medical University of Vienna, Dept. of Anaesthesiology, Critical Care and Pain Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
David M Baron, MD, Assoc. Prof. PD Dr. David Baron, EDIC, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT04980820
Other Study ID Numbers:
  • 1144/2021
First Posted:
Jul 28, 2021
Last Update Posted:
Jan 4, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2022